Some markers identified in this work as secreted proteins (e.g., DDR1 and UCHL1) have been positioned as tissue markers in studies by other groups, and the protein expression level of these markers was previously determined directly in tumor samples by immunohistochemistry based on the antigen–antibody interaction [50,51]. The gene discussed is UCHL1; the disease is neoplasm.